Publications
Securities Class Actions in the Life Sciences Sector
Spring 2025
Sidley is pleased to present its annual review addressing developments in securities class actions brought against life sciences companies in 2024.
In this publication, we begin with an overview and analysis of trends in federal district court and appellate decisions in these cases. We then provide summaries of the 49 decisions surveyed. Finally, we catalog the new securities class action complaints filed against life sciences companies in 2024.
Click here to download the PDF.
Click here to view a two-page summary.
Click here to order hard copies. Limited supply available.
Knowledge Management Lawyer Zarine Alam also contributed to the 2024 annual report.
連絡先
得意分野
Suggested News & Insights
A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026Sidley & Trinity Capital Life Sciences ReceptionThursday, October 22, 2026Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Sidley Represents GSK in Connection With Its €3.5 Billion Issuance of NotesSeptember 17, 2026HHS Secretary Announces Intent to Extend HHS-OIG Exclusion Authority to CMS, Expanding the Administration’s Anti-Fraud CampaignSeptember 16, 2026FDA and SEC Announce Coordination on Scrutiny of Public DisclosuresSeptember 16, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory